Quick Details
- Whatsapp:+393512941528
- Whatsapp:+447452273447
- Use:Hearing aid
- Warranty:2-years
- Processing Time:4-days
- Port:Milano
- Supply Ability: 200 Pieces Per Day
- Brand Name:Maico
- Model Number:ERO•SCAN OAE Diagnostic Screener
- Place of Origin:Italy
- Type:OAE Diagnostic Screener
- Brand Name:Maico
WHATSAPP: +393512941528
WHATSAPP: +44 7452273447
Features:
* Performing screening and diagnostic measurements
of TEOAE and / or DPOAE
* Sharp, colored organic LED display
* Fast automatic testing with Pass / Refer outcome and
graphical test result display
* 2 DP and 2 TE screening protocols
* 5 DP and 3 TE diagnostic protocols of which 4 DP
and 2 TE are customizable protocols
* High noise immunity for operation in normal clinical
environment
* Lightweight, small earprobe
* Wireless communication to PC and optional thermal printer
Technical Data:
ERO•SCAN Specifications
Power Supply Lithium-Ion rechargeable
Battery Life 1000 tests per charge,
minimum 15 hours on-time
Dimensions 66 mm x 31 mm x 145 mm
Weight 176 g
User Interface OLED display
4-button keypad
PC Interface USB micro, Wireless connection
Power Supply Specifications
Output 5.0 V DC, 1.6 A
Input 100 V-240 V AC, 50/60 Hz,
400mA
Printer optional
Type Thermal dot matrix
Speed 50 to 80 mm / second
Operating Noise < 50 dB SPL
Power Supply 7.4 V lithium battery or mains
100 V to 240 V 50/60 Hz
Weight 200 g
Data Transfer Wireless
Test Specifications
Measurement Type DPOAE (Distortion Product Otoacustic
Emissions)
TEOAE (Transient Evoked Otoacoustic
Emmisions)
Frequency Range Screening Version
DPOAE: 2.0 kHz to 5.0 kHz
TEOAE: 1.5 kHz to 4.0 kHz
Diagnostic Version
DPOAE: 1.5 kHz to 12.0 kHz
TEOAE: 0.7 kHz to 4.0 kHz
Stimulus Intensity Range DPOAE: 40 dB SPL to 70 dB SPL
TEOAE: 80 dB SPL peak equivalent
(±3 dB)
Micro-Probe Specifications
Microphone System Noise -20 dB SPL at 2 kHz (1 Hz bandwidth)/
-13 dB SPL at 1
kHz (1 Hz bandwidth)
Cable Length 1.1 m
Weight 28 g
Standards
IEC 60645-6 2009 Type 2, IEC 60601-1 Type B, IEC 60601-1-2,
according to the class IIa of the EU medical directive 93/42/EEC,
FDA 510(k) K150491